Record

RefNoEC/2002/13
LevelItem
TitleHastie, Nicholas Dixon: certificate of election to the Royal Society
CitationDistinguished for his original and varied contributions to mammalian developmental genetics, genome organisation and gene expression. His early work established the abundance of messenger RNAs during mouse development, and led to the cloning of several genes that are expressed specifically in the liver. Further studies of the serpin gene family uncovered the first clear example of "accelerated protein evolution". At this time he also identified several novel repetitive elements in the mouse genome. His group was the first to characterise mammalian telomeres, and to demonstrate telomere?shortening with age in man. Nick Hastie's current work is focused on human developmental mutations, notably Wilm's Tumour and Aniridia. His group demonstrated that aniridia, and the mouse equivalent, smalleye, are caused by mutations in the PAX?6 gene. He continues to make incisive contributions to our understanding of the role of WT1, the candidate Wilm's Tumour gene, in development of the kidney and gonad.
AccessStatusClosed
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView